Successful Venetoclax Salvage in the Setting of Refractory, Dialysis-Dependent Multiple Myeloma With T(11;14)

Haematologica- Italy

doi 10.3324/haematol.2019.228338

Full Text

Abstract

Available in

Categories

Date

November 21, 2019

Authors

Caoimhe Delaney

Alessandro Natoni

Michael O’Dwyer

Janusz Krawczyk

Publisher

Ferrata Storti Foundation (Haematologica)

Related search

Real-World Data on Safety and Efficacy of Venetoclax-Based Regimens in Relapsed/Refractory T(11;14) Multiple Myeloma

British Journal of Haematology

English

MYEOV (Myeloma Overexpressed (In a Subset of T(11;14) Positive Multiple Myelomas))

Atlas of Genetics and Cytogenetics in Oncology and Haematology

Cancer Research

English

The CCND1 C.870G>A Polymorphism Is a Risk Factor for T(11;14)(q13;q32) Multiple Myeloma

Nature Genetics

English

Translocation T(11;14) (Q13;q32) and Genomic Imbalances in Multi-Ethnic Multiple Myeloma Patients: A Malaysian Study

Hematology Reports

English

Durable Remission With Salvage Second Autotransplants in Patients With Multiple Myeloma

Cancer Research

English

Bendamustine in Patients With Relapsed or Refractory Multiple Myeloma

European Journal of Medical Research

English

Carfilzomib for Relapsed or Refractory Multiple Myeloma

The Lancet Oncology

English

Prm272 - The Eunethta Transferability Tool: Application to Novel Treatments for Relapsed Refractory Multiple Myeloma in the Irish Healthcare Setting

Value in Health

Occupational Health

English

Impact of High-Cut-Off Dialysis on Renal Recovery in Dialysis-Dependent Multiple Myeloma Patients: Results From a Case-Control Study

Multidisciplinary

English